the prognosis of malignant lymphomas , hodgkin ( hl ) and non-hodgkin ( nhl ) , varies in a very wide range , from a 60-70 % survival at 10 years in hl to a median survival of 2-3 years in high-grade nhl .
C0024299
malignant lymphomas
C0024305
nhl